Cargando…
SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century?
Autores principales: | Correale, Michele, Tricarico, Lucia, Iacoviello, Massimo, Brunetti, Natale Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095017/ https://www.ncbi.nlm.nih.gov/pubmed/37048778 http://dx.doi.org/10.3390/jcm12072695 |
Ejemplares similares
-
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
por: Correale, Michele, et al.
Publicado: (2021) -
SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?
por: Kounatidis, Dimitris, et al.
Publicado: (2023) -
Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction
por: Alcidi, Gianmarco, et al.
Publicado: (2023) -
Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches
por: Correale, Michele, et al.
Publicado: (2021) -
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience
por: Tabella, Erika, et al.
Publicado: (2023)